Clinical Trial

To Evaluate the Efficacy and Safety of RSS0393 Ointment in Patients With Plaque Psoriasis Phase II Study

Name: To Evaluate the Efficacy and Safety of RSS0393 Ointment in Patients With Plaque Psoriasis Phase II Study — clinical trial record (NCT06918743)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Record status

This record was last updated April 9, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.

Summary

To evaluate the efficacy and safety of RSS0393 ointment in patients with plaque psoriasis Phase II study

Trial Details

NCT Number	NCT06918743
Lead Sponsor	Jiangsu HengRui Medicine Co., Ltd.
Conditions	Psoriatic Subjects
Enrollment	147 participants
Start Date	2025-04
Primary Completion	2026-03 (estimated)
Study Completion	2026-03 (estimated)
Updated on ClinicalTrials.gov	2025-04-09